- Are you postmenopausal and aged between 55 and 80 years?
- Do you have osteoporosis?
- Do you weigh between 50 kg and 90 kg (approx 110 to 198 lbs)?
If you can answer “yes” to these questions, then we would like to hear from you.
We are currently looking for postmenopausal women with osteoporosis who may be interested in joining the ROSALIA clinical research study.
The ROSALIA Study is evaluating the effectiveness of a proposed biosimilar* investigational study drug called CP2411 for postmenopausal women with osteoporosis.
If the study is suitable for you and you choose to participate, the study drug and all study-related care will be provided to you. Your participation in the ROSALIA Study is entirely voluntary and you can leave the study at any time, for any reason.
*A biosimilar is a drug designed to have active properties similar to those of a drug that has previously been approved for use.
To learn more, please call our East Wichita location at 316-689-6609
Please fill out your information below and a Heartland Research specialist will contact you with more information for this study.
The information you provide is entered in our secure, password protected database. The provided information will only be used to contact you to tell you more about the study. You have the choice to have your information saved or removed from our records. If you elect to have contact information saved within our database, it will remain indefinitely. To be removed please call a Heartland Research specialist at 316-689-6634 or email@example.com